University of Southern Denmark A fine balance epigenetic control of cellular quiescence by the tumor suppressor PRDM2/RIZ at a bivalent domain in the cyclin a gene Cheedipudi, Sirisha; Puri, Deepika; Saleh, Amena; Gala, Hardik P; Rumman, Mohammed; Pillai, Malini S; Sreenivas, Prethish; Arora, Reety; Sellathurai, Jeeva; Schrøder, Henrik Daa; Mishra, Rakesh K; Dhawan, Jyotsna Published in: Nucleic Acids Research DOI: 10.1093/nar/gkv567 Publication date: 2015 Document version: Final published version Document license: CC BY-NC Citation for pulished version (APA): Cheedipudi, S., Puri, D., Saleh, A., Gala, H. P., Rumman, M., Pillai, M. S., Sreenivas, P., Arora, R., Sellathurai, J., Schrøder, H. D., Mishra, R. K., & Dhawan, J. (2015). A fine balance: epigenetic control of cellular quiescence by the tumor suppressor PRDM2/RIZ at a bivalent domain in the cyclin a gene. Nucleic Acids Research, 43(13), 6236-6256. https://doi.org/10.1093/nar/gkv567 Go to publication entry in University of Southern Denmark's Research Portal Terms of use This work is brought to you by the University of Southern Denmark. Unless otherwise specified it has been shared according to the terms for self-archiving. If no other license is stated, these terms apply: • You may download this work for personal use only. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying this open access version If you believe that this document breaches copyright please contact us providing details and we will investigate your claim. Please direct all enquiries to [email protected] Download date: 05. Oct. 2021 6236–6256 Nucleic Acids Research, 2015, Vol. 43, No. 13 Published online 3 June 2015 doi: 10.1093/nar/gkv567 A fine balance: epigenetic control of cellular quiescence by the tumor suppressor PRDM2/RIZ at a bivalent domain in the cyclin a gene Sirisha Cheedipudi1,2,4,†, Deepika Puri1,5,†, Amena Saleh1,6, Hardik P. Gala1,2, Mohammed Rumman1,6, Malini S. Pillai1, Prethish Sreenivas1,2, Reety Arora1, Jeeva Sellathurai3, Henrik Daa Schrøder3, Rakesh K. Mishra2 and Jyotsna Dhawan1,2,* 1Institute for Stem Cell Biology and Regenerative Medicine, National Center for Biological Sciences, GKVK Post, Bellary Road, Bangalore 560065, India, 2Council of Scientific and Industrial Research-Centre for Cellular and Molecular Biology, Hyderabad 500 007, India, 3Institute of Clinical Research, SDU Muscle Research Cluster (SMRC), University of Southern Denmark, Odense 5000 C, Denmark, 4Max Planck Institute for Heart and Lung Research, Bad Nauheim 61231, Germany, 5Max Planck Institute of Immunobiology and Epigenetics, Freiburg D-79108, Germany and 6Manipal University, Manipal 576104 India Received October 25, 2014; Revised April 23, 2015; Accepted May 19, 2015 ABSTRACT preserves key functions of the quiescent state, with implications for stem cell self-renewal. Adult stem cell quiescence is critical to ensure re- generation while minimizing tumorigenesis. Epige- netic regulation contributes to cell cycle control and INTRODUCTION differentiation, but few regulators of the chromatin Epigenetic regulatory mechanisms play a crucial role in cell state in quiescent cells are known. Here we report fate decisions, whereby global and local controls are im- that the tumor suppressor PRDM2/RIZ, an H3K9 posed on chromatin and result in distinct transcriptional methyltransferase, is enriched in quiescent muscle programs. The epi-genome of pluripotent embryonic stem stem cells in vivo and controls reversible quiescence cells (ESC) is highly permissive, accommodating both self- in cultured myoblasts. We find that PRDM2 asso- renewal and broad differentiation potential. During devel- opment, chromatin configuration becomes progressively re- ciates with >4400 promoters in G0 myoblasts, 55% of which are also marked with H3K9me2 and enriched strictive as cells commit and differentiate into specific lin- eages. Regulation at the level of chromatin is emerging as a for myogenic, cell cycle and developmental regula- primary determinant in the establishment and maintenance tors. Knockdown of PRDM2 alters histone methyla- of heritable gene expression patterns (1–4). tion at key promoters such as Myogenin and Cy- The global chromatin landscape is controlled by a hier- clinA2 (CCNA2), and subverts the quiescence pro- archy of mechanisms, of which regulation at the level of gram via global de-repression of myogenesis, and the basic unit, the nucleosome, is best understood. Inter- hyper-repression of the cell cycle. Further, PRDM2 actions of the core nucleosomal histones (H2A, H2B, H3 acts upstream of the repressive PRC2 complex in and H4) leave their N terminal tails accessible to a range G0. We identify a novel G0-specific bivalent chro- of post-translational modifications that are deposited, read matin domain in the CCNA2 locus. PRDM2 pro- or erased by a wide variety of chromatin modifying en- tein interacts with the PRC2 protein EZH2 and reg- zymes, altering the packaging of DNA. Dynamic changes ulates its association with the bivalent domain in in histone modifications can therefore also alter DNA- transcription factor interactions, and may either accom- the CCNA2 gene. Our results suggest that induc- pany or precede transcriptional activation or repression. tion of PRDM2 in G0 ensures that two antagonis- Thus, the ‘histone code’ embodies gene regulatory infor- tic programs––myogenesis and the cell cycle––while mation that is embedded in complex cell type- and cell stalled, are poised for reactivation. Together, these state-specific combinations of histone modifications (5). results indicate that epigenetic regulation by PRDM2 Typically, in addition to the requisite RNA polymerase II (pol II) binding, transcription activation correlates with tri- *To whom correspondence should be addressed. Tel: +91-80-23666016; Fax: +91-80-2363-6662; Email: [email protected] †These authors contributed equally to the paper as first authors. C The Author(s) 2015. Published by Oxford University Press on behalf of Nucleic Acids Research. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact [email protected] Nucleic Acids Research, 2015, Vol. 43, No. 13 6237 methylation of lysine 4 of H3 (H3K4me3), together with hi- posit H3K27me3 marks and permanently silence cell cycle stone acetylation (H3K9Ac). By contrast, transcription re- genes during differentiation (26). In human cells, p130 and pression often involves tri-methylation of lysine 27 of H3 E2F factors associate with MuvB-like proteins in G0, form- (H3K27me3) and di-or tri-methylation of lysine 9 of H3 ing the DREAM complex that is involved in repression of (H3K9me2/3), through the recruitment of repressive pro- cell cycle genes (27) and in Drosophila, dREAM is impli- tein complexes. cated in repression of a wide variety of developmental genes Heritability of epigenetic information has to meet the (28). challenge of chromatin disassembly and reassembly dur- In ESC, cell fate loci are located in ‘bivalent domains’ ing DNA synthesis, necessitating cellular memory mecha- (marked by both H3K27me3 and H3K4me3), in a tran- nisms, particularly in adult stem cells (ASC). Adult tissues scriptionally repressed state poised for activation (29–31). are comprised of cells in distinct non-proliferating states Lineage commitment correlates with a shift to unique mark- with distinct functions. In skeletal muscle, differentiated ing by tri-methylation of either H3K27 (silencing) or H3K4 myofibers are permanently arrested (post-mitotic), buta (activation), which underlies and reinforces cell fate choices. rare population of satellite stem cells enters an alternate ASC are also thought to maintain a chromatin configura- cell cycle exit (quiescence or G0), retaining the option to tion permissive to a (restricted) set of alternate fates (4). reactivate and repair damage (reviewed in (6)). Recent evi- Recent reports describe bivalent domains in ASC including dence suggests that rather than a state of passive hiberna- muscle SCs (32), but mechanisms of poising are unexplored. tion entered when nutrients or mitogens are limiting, the Using genome-wide location analysis, transcriptome quiescence program is actively regulated at transcriptional analysis and RNAi, we now report that a single regulator, (7–10) and epigenetic (11–13) levels. Deregulation of quies- an H3K9 methyl transferase PRDM2, is induced in quies- cence may underlie both tumorigenesis (failure to enter G0 cence and binds to thousands of promoters in quiescent my- leading to uncontrolled proliferation), as well as degenera- oblasts, over half of which are also marked by the repressive tive disease (failure to exit G0 leading to loss of progenitor H3K9me2 mark. PRDM2 acts in two modes on differen- function), necessitating an understanding of mechanisms tiation versus cell cycle target genes––while it represses the that control this arrested state. activity of the Myogenin promoter in quiescence, this epige- The mechanisms by which stem cells achieve cellular netic regulator also controls association of the PRC2 com- memory to keep specific regions of their genome repressed plex at a novel G0-specific bivalent domain in the CCNA2 but ready to respond to regenerative
Details
-
File Typepdf
-
Upload Time-
-
Content LanguagesEnglish
-
Upload UserAnonymous/Not logged-in
-
File Pages22 Page
-
File Size-